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THE HUMAN OROPHARYNX is home to a multi-tude of different bacteria and fungi [1]. In
sharp contradistinction, the human trachea and
bronchial tree normally harbor no bacteria.
Nasal or orotracheal intubation places a plastic
(usually) foreign body through the orophar-
ynx, thence between and below the true vocal
cords, ideally to rest in the proximal tracheo-
bronchial tree. Invariably, the initially sterile
endotracheal tube (ETT) becomes contami-
nated with the patient’s resident bacteria dur-
ing its nasopharyngeal or oropharyngeal pas-
sage to the proximal trachea.
Our current medical climate embraces infec-
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ABSTRACT
Background: There is a paucity of data regarding whether sterile handling of endotracheal
tubes (ETTs) impacts the incidence and prevalence of pneumonia in the emergency, urgent,
or elective clinical scenarios. Intensive care units employ infection control and reduction
schemes to reduce pneumonia rates.
Methods: A MEDLINE search of the English-language literature for the last 30 years was
performed using the keywords “endotracheal intubation,” “intubation,” “pneumonia,” “si-
nusitis,” “tracheobronchitis,” “nosocomial infection,” and “infection.” Data were limited to
those papers addressing the role of sterile handling or passage of ETTs, infection with an-
tibiotic-resistant micro-organisms, antibiotic prophylaxis, and the role of virulence determi-
nants in supporting invasive infection. Also, a convenience sample of a single author’s pa-
tients requiring tracheal intubation was undertaken. Data were acquired on tube handling,
success of insertion, and subsequent occurrence of pneumonia.
Results: Virtually no data exist on the impact of sterile ETT handling, but unsterile ma-
nipulation of the ETT prior to insertion is common (112 of 154 intubation events). Within the
limited patient sample, no conclusions may be drawn regarding the impact of unsterile han-
dling on pneumonia rates, although sinusitis after nasotracheal intubation clearly increases
the incidence of pneumonia. Biofilm generation as a facilitator of bacterial colonization of ar-
tificial airway surfaces is a ubiquitous virulence determinant that is not ameliorated by an-
tibiotic administration.
Conclusions: Unsterile ETT handling and insertion techniques are not clearly associated
with pneumonia induction, but physiologically sound approaches that retard biofilm pro-
duction may decrease pneumonia rates.
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tion-reduction measures spanning central ve-
nous catheter insertion [2], ventilator-associ-
ated pneumonia (VAP) [3], and appropriate
surgical antibiotic prophylaxis [4]. These ini-
tiatives raise a number of questions regarding
endotracheal intubation: (1) How does such
intubation fit into the infection-reduction
scheme? (2) What is the role of sterile handling
of an ETT prior to oropharyngeal passage? and
(3) Does endotracheal intubation merit antibi-
otic prophylaxis?
INFECTION-REDUCTION PROTOCOLS
Endotracheal intubation occurs in one of
three settings: Emergency, urgent, or elective.
Moreover, because some patients require long-
term endotracheal intubation, a fourth setting
may be recognized: Chronic intubation, most
commonly with a tracheostomy tube. This dis-
cussion addresses the first three settings, as pa-
tients with a chronic need for intubation rep-
resent a different population with regard to
airway violation, colonization, and infection
risk [5]. It is increasingly clear that tracheal in-
tubation confers an additive risk with regard
to hospital-acquired pneumonia (HAP) as well
as a special subset of that entity—VAP [6].
Moreover, there is an important influence of
underlying disease processes and non-respira-
tory system intervention, as HAP rates are
markedly higher in surgical than in medical
ICUs [7].
Clearly, tracheal intubation is unavoidable in
emergency situations such as cardiac arrest (in
persons desiring to be resuscitated) and after
injury leading to hemodynamic instability. Tra-
cheal intubation frequently is unavoidable in
the urgent situation as well. However, many of
these patients may be salvaged using non-in-
vasive ventilator techniques such as bilevel
positive airway pressure (BiPAP) or negative-
pressure ventilation [8]. Non-invasive ventila-
tory techniques carry a lower risk of VAP than
does ventilatory support via an indwelling ETT
[9]. Thus, avoiding tracheal instrumentation
when possible supports infection reduction
measures. Nonetheless, this posture is fre-
quently irrelevant clinically, as many patients
(especially children) presenting to an emer-
gency department or an intensive care unit re-
quire life-saving tracheal access. The exigencies
of emergency intubation may impact ideal tube
handling and placement. Therefore, these sub-
sets of patients probably will not be impacted
by mechanical recommendations to reduce en-
dotracheal intubation-associated contamina-
tion–colonization–infection.
The patient population undergoing elective
intubation, on the other hand, is a prime target
for focused intervention to reduce the likeli-
hood of mechanical transfer of bacteria from
the oropharynx to the tracheobronchial tree
and the size of any inoculum. It is intuitive that
an unobstructed view of the vocal cords will
facilitate passage of an ETT through those
cords with minimal contact with oropharyn-
geal structures. Such maneuvers will minimize
the density of adherent bacteria carried inad-
vertently into the lower airway by an orally
placed ETT. No such maneuvering is possible
for nasally placed tubes, as they necessarily tra-
verse the nasal and oral passages in intimate
contact with mucosal surfaces. To date, there
are few data on the effect of sterile passage of
oral ETTs on subsequent rates of tracheobron-
chitis or pneumonia. The extant data indicate
that oropharyngeal preparation with a topical
solution such as povidone–iodine reduces the
bacterial recovery rates from ETTs and the pos-
terior pharynx in patients undergoing short-
term tracheal intubation [10].
Regardless, there are parallels in other are-
nas that support the paradigm of sterile pas-
sage of ETTs. Operating room procedures are,
ideally, conducted in a sterile fashion. Clearly,
head and neck procedures such as sinus sur-
gery, transsphenoidal hypophysectomy, and
tracheostomy all traverse non-sterile environ-
ments. Early work by Harvey Cushing, operat-
ing in a minimal-to-no antibiotic era, achieved
infection rates below 2% after transsphenoidal
surgery. How do we reconcile our abiding
commitment to surgical field sterility with low
infection rates operating through contaminated
spaces, and does that reconciliation relate to en-
dotracheal intubation? The answer lies in host
defenses.
First, one must recognize that no operation
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is completely sterile. Second, operative field
and patient preparation reduce surface bacte-
ria and minimize entry of bacteria into sterile
tissue planes. Third, antimicrobials serve as an
adjunct to host defense in handling the bacter-
ial inoculum that invariably results from inci-
sion and tissue handling; endogenous humoral
and cellular defenses, including the important
Toll-like receptor complexes, shoulder the bur-
den of dealing with bacterial contamination to
prevent invasion [11]. These observations re-
late to endotracheal intubation, as it must be
recognized that optimal ETT placement is a
clean or clean-contaminated technique, not a
sterile procedure. In the majority of cases, host
defenses should be able to thwart a bacterial
inoculum in the tracheobronchial tree. It is in-
tuitive, although scientific data are absent, that
because it is the patient’s own flora that is trans-
mitted in the elective intubation scenario, host
defenses should already recognize those bacte-
ria, respond readily to their surface antigens,
and eliminate them rapidly from the normally
sterile tracheobronchial tree. If this hypothesis
is correct, then the corollary should also be true:
Foreign organisms present a more difficult
challenge to host defenses than does the native
flora. This idea may have important implica-
tions for ETT handling prior to insertion.
ENDOTRACHEAL TUBE HANDLING
Endotracheal tubes arrive in a sterile pack-
age despite their intended passage through the
heavily colonized human oropharynx. Of what
value, then, is the sterile packaging? The value
is more theoretical than proved in that there is
no study of any kind that addresses sterile han-
dling of ETTs prior to placement. Sterile pro-
cessing gives the clinician a tube devoid of non-
resident bacteria, impacting the bacterial
inoculum presented to the patient’s tracheo-
bronchial tree. Such a scheme may be impor-
tant in the immunocompromised host whose
defenses are impaired or functionally absent.
Instead, there is a wealth of accumulated clin-
ical wisdom justifying non-sterile handling of
ETTs in the field by emergency medical ser-
vices personnel, as well as by the emergency
department, operating room, intensive care
unit, and general ward. Further buttressing this
observation is the absence of deleterious out-
comes vis-à-vis infection with short-term
nasally placed ETTs although it is clear that
trans-nasal airway intubation increases the rate
of tracheobronchitis and subsequent pneumo-
nia [12].
Nonetheless, it makes sense to avoid intro-
ducing, not only non-resident bacteria, but
particularly nosocomial single- or multi-drug-
resistant bacteria into a patient’s tracheobron-
chial tree. A multitude of pathogens may sur-
vive on surfaces with and sometimes without
moisture, to thrive when introduced into a sup-
portive environment [13]. Such pathogens in-
clude Clostridium difficile spores, Acinetobacter
spp., Pseudomonas spp., vancomycin-resistant
Enterococcus spp. (VRE), and a number of
viruses and fungi [14]. Gram-negative patho-
gens with genetic wiring for extended-spec-
trum -lactamase (ESBL) production may be
grouped conveniently under the acronym
SPACE (Serratia, Pseudomonas/Proteus, Acineto-
bacter, Citrobacter, and Enterobacter) [15–18].
Other pathogens may acquire plasmids for
multi-drug resistance (i.e., VRE). Introducing
these pathogens from the environment may be
disastrous for an already critically ill patient
whose immune defenses are inadequate and
whose original flora has been altered by con-
comitant antibiotic therapy.
That non-sterile ETT handling is common is
underscored by a series of convenience-sam-
pled observations in consecutive patients re-
quiring endotracheal intubation over the last
nine months in the clinical practice of one of
the authors (LJK). The observations derive
from 154 operations (42 emergency, 112 elec-
tive) that necessitated endotracheal intubation
and were observed directly by that author. In
all 154, the sterile ETT was cannulated with a
non-sterile stylet. The data on ETT handling
and intubation success are displayed in Figure
1. Figure 2 depicts the breakdown of pneumo-
nia according to the nature of the need for in-
tubation (elective vs. emergency). Because of
the small numbers, the significance of the pneu-




FIG. 1. Depiction of outcomes of 154 patients by urgency of intubation and endotracheal tube handling. () nitrile
gloves  tube handling with non-sterile nitrile gloves used to manipulate medications, move patient, or touch other
non-sterile surfaces; VRE  vancomycin-resistant Enterococcus faecium derived from blood or body cavity other than
urinary tract or open wounds; C. difficile  Clostridium difficile colitis; ESBL  extended-spectrum -lactamase-pro-
ducing gram-negative bacillus infection; derived from pulmonary source in all instances.
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FIG. 2. Classification of patients by urgency of intubation and subsequent identification of pneumonia. HIV; ()
viral load  infected with human immunodeficiency virus but without detectable serum titer; ALI/ARDS  acute
lung injury/acute respiratory distress syndrome.
ANTIBIOTIC PROPHYLAXIS 
OF ENDOTRACHEAL INTUBATION
To date, no study supports prophylactic sys-
temic antibiotics for endotracheal intubation. In
fact, whereas many studies identify a higher
risk of HAP and VAP with prolonged intuba-
tion, no study supports antibiotic administra-
tion to minimize that risk. Instead, mechanical
measures such as head-of-bed elevation,
chlorhexidine oral cleansing, and active wean-
ing are standards of care [19]. Numerous stud-
ies document an adverse impact of antibiotic
prophylaxis where none is needed or with
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overly broad-spectrum agents [20,21]. Such
deleterious effects include prolonged intensive
care unit and hospital stays, a higher incidence
of catheter-related infections, and promotion of
resistant pathogens, including fungi. Most
strongly associated with selection of resistant
pathogens are third-generation cephalosporins
and the fluoroquinolones—“collateral dam-
age” from inappropriate antibiotic prescription
practices [22–24]. Therefore, there currently is
no role for systemic antibiotic prophylaxis of
endotracheal intubation despite knowledge
that the resident and non-resident bacteria are
inadvertently but regularly inoculated into the
normally sterile tracheobronchial tree. How-
ever, the reader should be aware that no study
has segregated those patients with impaired
host defenses from those without, nor assessed
endotracheal intubation with regard to ETT
handling and insertion technique.
Instead, there is a growing body of evidence
that local antimicrobial control measures may
be effective in reducing the bacterial burden of
the tracheobronchial tree. Novel advances in
tube construction and coating are being tested
[25]. The combination of gentian violet and
chlorhexidine (gendine) in a solution that may
be applied to either ETTs or urinary catheters
provides one means of preparing such devices
for long-term placement [26]. Gendine pro-
vides three weeks of antibacterial activity
against bronchoalveolar lavage fluid contain-
ing methicillin-resistant Staphylococcus aureus
and Pseudomonas aeruginosa, and treated uri-
nary catheters maintained potency against
urine containing Escherichia coli for eight weeks.
A provocative study in dogs comparing silver
hydrogel-coated endotracheal tubes with un-
treated endotracheal tubes identified delayed
appearance of aerobic bacteria in the endotra-
cheal tube after a buccal P. aeruginosa challenge
[27]. Furthermore, in dogs intubated with the
coated tubes, there were decreases in the total
bacterial burden in the lungs and in histologic
evidence of inflammation (e.g., hyperemia,
edema, cellular infiltration, and bacteria). A re-
lated study in sheep extended the observations
to a smaller bacterial burden when ETTs coated
with silver sulfadiazine and chlorhexidine
were included in the ventilator circuit [28]. A
recent study in human beings documented de-
creased density of bacteria on silver-coated
ETTs, suggesting a potential role for silver ions
in diminishing the bacterial burden on the in-
terior of endotracheal catheters [29].
Of particular importance, silver ions may im-
pact the biofilm that forms on the interior of
endotracheal tubes. Biofilm formation has been
implicated as an important step in the pro-
gression of bacterial airway colonization to in-
vasive infection. Normal respiratory mucosa is
rich in antimicrobial proteins and polypeptides
that retard biofilm growth [30]. In an analogous
manner, silver ions may well serve as an anti-
biofilm therapeutic agent. Biofilm production
is a species-specific virulence determinant
linked to genetic diversity [31]. Neuraminidase
is produced by a host of respiratory pathogens
and functions as a virulence determinant as
well. Neuraminidase cleaves sialic acid resi-
dues from respiratory epithelium and uncov-
ers bacterial adhesion targets. Strains of Pseudo-
monas whose ability to generate neuraminidase
has been deleted genetically are unable to es-
tablish an invasive infection after direct inocu-
lation into a murine respiratory system [31].
Importantly, diminished neuraminidase pro-
duction also correlates with decreased biofilm
generation. The clinical relevance of biofilm
generation extends to nasogastric tubes (NGTs)
in that there is a relation among NGT biofilm,
aspiration pneumonia, and antibiotic resistance
[32]. Biofilm was noted to develop on 60% of
NGTs within a single day; therefore, prophy-
lactic measures to retard biofilm genesis may
be crucial in reducing nosocomial infection.
CONCLUSIONS
There is a paucity of data about sterile han-
dling of ETTs for orotracheal intubation. It is
likely that in order to detect a benefit from ster-
ile handling, patients requiring intubation will
need to be evaluated in two populations: Those
who have not recently required a tracheal de-
vice, and those with an indwelling device or a
recently removed device. The differences be-
tween these groups are likely related to differ-
ent flora stemming from the location within a
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hospital as well as concomitant antibiotic ther-
apy. At present, limiting the introduction of
non-resident flora from the environment into a
patient’s trachea remains grounded in sound
physiology and microbiology. Sterile handling
of the ETT helps maximize the success of the
patient’s native immune system by reducing the
bacterial burden delivered to the tracheal mu-
cosa. Future clinical trials will determine the
value of ETT coating with an antiseptic agent
to further reduce bacterial colonization and sub-
sequent infection of the tracheobronchial tree.
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